Answers are grounded in this paper and cite their sources.
Celiac disease (CD) is a gluten-dependent chronic inflammatory disease. Anthocyanins (ACN) like cyanidin-3-glucoside (C3G) and delphinidin-3-glucoside (D3G) may possess anti-inflammatory properties. This study investigated their effects on cytokine-mediated inflammatory responses in Caco-2 intestinal epithelial and differentiated THP-1 cells. The cells were treated with C3G or D3G and stimulated with interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α). Inflammatory markers were analyzed at the gene expression and protein levels, and ACN stability was assessed by UHPLC-ESI-QqQ-MS/MS. D3G, but not C3G attenuated IFN-γ-induced monocyte chemoattractant protein-1 (MCP-1) and IFN-γ-induced protein 10 (IP-10) secretion in THP-1 cells as well as TNF-α-induced C-X-C motif chemokine ligand 1 (CXCL1), IP-10, and interleukin 8 (IL-8) secretion in Caco-2 cells. ACN pre-treatment also reduced transglutaminase 2 (TG2) mRNA expression in Caco-2 cells. Further analysis using a solid-phase IFNGR1-IFN-γ binding assay suggested interactions of C3G and D3G with the IFN-γ receptor. Overall, our results indicate that ACN, especially D3G, may modulate selected cytokine-induced inflammatory responses relevant to CD.
No takes yet. Share an insight, caveat, or question.
Diers et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: